Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease
BACKGROUND and aim: Macrolide antibiotics are widely used in the treatment of suppurative lung diseases including cystic fibrosis (CF), the most common inherited fatal disease in the Caucasian population. This condition is characterized by secondary Pseudomonas infection resulting in neutrophil infi...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2004-01-01
|
Series: | Mediators of Inflammation |
Online Access: | http://dx.doi.org/10.1080/09629350410001688495 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832552609768013824 |
---|---|
author | Alexander L. Pukhalsky Galina V. Shmarina Nikolai I. Kapranov Svetlana N. Kokarovtseva Daria Pukhalskaya Natalia J. Kashirskaja |
author_facet | Alexander L. Pukhalsky Galina V. Shmarina Nikolai I. Kapranov Svetlana N. Kokarovtseva Daria Pukhalskaya Natalia J. Kashirskaja |
author_sort | Alexander L. Pukhalsky |
collection | DOAJ |
description | BACKGROUND and aim: Macrolide antibiotics are widely used in the treatment of suppurative lung diseases including cystic fibrosis (CF), the most common inherited fatal disease in the Caucasian population. This condition is characterized by secondary Pseudomonas infection resulting in neutrophil infiltration within the airways. The aim of the study was to investigate the evolution of inflammatory process in CF patients receiving long-term clarithromycin therapy. |
format | Article |
id | doaj-art-f5d0752ef12f4fb9b62094b4cc7f7362 |
institution | Kabale University |
issn | 0962-9351 1466-1861 |
language | English |
publishDate | 2004-01-01 |
publisher | Wiley |
record_format | Article |
series | Mediators of Inflammation |
spelling | doaj-art-f5d0752ef12f4fb9b62094b4cc7f73622025-02-03T05:58:20ZengWileyMediators of Inflammation0962-93511466-18612004-01-0113211111710.1080/09629350410001688495Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung diseaseAlexander L. Pukhalsky0Galina V. Shmarina1Nikolai I. Kapranov2Svetlana N. Kokarovtseva3Daria Pukhalskaya4Natalia J. Kashirskaja5Research Centre for Medical Genetics, 1 Moskvorechie Street, Moscow 115478, RussiaResearch Centre for Medical Genetics, 1 Moskvorechie Street, Moscow 115478, RussiaResearch Centre for Medical Genetics, 1 Moskvorechie Street, Moscow 115478, RussiaResearch Centre for Medical Genetics, 1 Moskvorechie Street, Moscow 115478, RussiaResearch Centre for Medical Genetics, 1 Moskvorechie Street, Moscow 115478, RussiaResearch Centre for Medical Genetics, 1 Moskvorechie Street, Moscow 115478, RussiaBACKGROUND and aim: Macrolide antibiotics are widely used in the treatment of suppurative lung diseases including cystic fibrosis (CF), the most common inherited fatal disease in the Caucasian population. This condition is characterized by secondary Pseudomonas infection resulting in neutrophil infiltration within the airways. The aim of the study was to investigate the evolution of inflammatory process in CF patients receiving long-term clarithromycin therapy.http://dx.doi.org/10.1080/09629350410001688495 |
spellingShingle | Alexander L. Pukhalsky Galina V. Shmarina Nikolai I. Kapranov Svetlana N. Kokarovtseva Daria Pukhalskaya Natalia J. Kashirskaja Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease Mediators of Inflammation |
title | Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease |
title_full | Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease |
title_fullStr | Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease |
title_full_unstemmed | Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease |
title_short | Anti-inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease |
title_sort | anti inflammatory and immunomodulating effects of clarithromycin in patients with cystic fibrosis lung disease |
url | http://dx.doi.org/10.1080/09629350410001688495 |
work_keys_str_mv | AT alexanderlpukhalsky antiinflammatoryandimmunomodulatingeffectsofclarithromycininpatientswithcysticfibrosislungdisease AT galinavshmarina antiinflammatoryandimmunomodulatingeffectsofclarithromycininpatientswithcysticfibrosislungdisease AT nikolaiikapranov antiinflammatoryandimmunomodulatingeffectsofclarithromycininpatientswithcysticfibrosislungdisease AT svetlanankokarovtseva antiinflammatoryandimmunomodulatingeffectsofclarithromycininpatientswithcysticfibrosislungdisease AT dariapukhalskaya antiinflammatoryandimmunomodulatingeffectsofclarithromycininpatientswithcysticfibrosislungdisease AT nataliajkashirskaja antiinflammatoryandimmunomodulatingeffectsofclarithromycininpatientswithcysticfibrosislungdisease |